All Posts: research
-
Called To Be a Doctor-Doctor: MD/PhDs at Georgetown Move From Bench to Bedside and Back
A subset of Georgetown students have made the decision to pursue both scientific research and clinical training through the MD/PhD program — allowing them to get the best of both worlds.
Category: GUMC Stories
-
Working in Extreme Heat: Deaths Underestimated and Protections Fall Short
Writing in the New England Journal of Medicine, two occupational health experts outline three necessary steps to close gaps in the management of workers impacted by extreme heat conditions in order to reduce heat-related illness and death.
Category: News Release
-
Drinking Kombucha May Reduce Blood Sugar Levels in People with Type 2 Diabetes
People with Type 2 diabetes who drank the fermented tea drink kombucha for four weeks had lower fasting blood glucose levels compared to when they consumed a similar-tasting placebo beverage, according to results from a clinical trial conducted by researchers at Georgetown University’s School of Health, the University of Nebraska-Lincoln and MedStar Health.
Category: News Release
-
Researchers Discuss Cognitive Function and Aging at 2nd Annual Healthy Aging Symposium
About 150 participants registered for this year’s Health Aging Symposium, which featured panel discussions on neuroscience, cancer, and healthy aging in the community, as well as poster presentations, a wine and cheese reception, a networking lunch and breakout sessions.
Category: GUMC Stories
-
Georgetown’s Center for Innovation in Global Health, in Partnership with the Government of Malawi, Leverages Emerging Tools To Accelerate an End to National HIV Epidemic
Georgetown University’s Center for Innovation in Global Health (CIGH), in partnership with the Republic of Malawi’s Ministry of Health, will advance research and policy toward the scale-up of long-acting injectable pre-exposure prophylaxis (PrEP) drugs to prevent HIV in the African country.
Category: News Release
-
Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer Uncovered
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to researchers at Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
The Curious Brain: Interdisciplinary Solutions for the Complex Problems of Neuroscience
Georgetown’s Interdisciplinary Program in Neuroscience offers doctoral students the ability to see neuroscience through the lens of multiple disciplines, not only allowing for the possibility of broadening or shifting their focus, but actively facilitating it.
Category: GUMC Stories
-
A New Understanding of How the Brain Processes and Stores Words We Hear
Georgetown University Medical Center neuroscientists say the brain’s auditory lexicon, a catalog of verbal language, is actually located in the front of the primary auditory cortex, not in back of it — a finding that upends a century-long understanding of this area of the brain. The new understanding matters because it may impact recovery and rehabilitation following a brain injury such as a stroke.
Category: News Release
-
Research To Help Patients Make Informed Decisions About Breast MRI
While many people think that breast cancer screening and mammography are synonymous, Claire Conley, PhD, wants people to know that women who are at higher than average risk for breast cancer may also receive a breast MRI.
Category: GUMC Stories
-
Researchers Develop Method to Monitor Cancer Radiotherapy Effects at the Cellular Level
Using complex molecular tools, Georgetown Lombardi researchers have determined how to measure, in real time, the effect that radiation treatment for cancer can have at the cellular level on surrounding healthy tissue.
Category: News Release